NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Daniel Renouf
British Columbia Cancer Agency - Vancouver / Canada
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4379502
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Daniel Renouf's MOST POPULAR ARTICLES
1-)
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoidsL Huang, A Holtzinger, I Jagan, M BeGora, I Lohse, N Ngai, C Nostro, ...Nature medicine 21 (11), 1364-1371, 20155572015
2-)
Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trialEM O’Reilly, DY Oh, N Dhani, DJ Renouf, MA Lee, W Sun, G Fisher, ...JAMA oncology 5 (10), 1431-1438, 20193072019
3-)
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionM Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ...Nature genetics 52 (2), 231-240, 20202662020
4-)
Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancerL Fong, A Hotson, JD Powderly, M Sznol, RS Heist, TK Choueiri, ...Cancer discovery 10 (1), 40-53, 20202762020
5-)
A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumorsPC McDonald, S Chia, PL Bedard, Q Chu, M Lyle, L Tang, M Singh, ...American journal of clinical oncology 43 (7), 484-490, 20202002020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept